Literature DB >> 9413545

Antioxidative activity of ginkgolides against superoxide in an aprotic environment.

H Scholtyssek1, W Damerau, R Wessel, I Schimke.   

Abstract

The terpene lactones ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J and bilobalide, which are components of a standardized extract (EGb 761) from leaves of Ginkgo biloba, as well as ginkgolide M from roots of G. biloba were studied regarding their reaction against superoxide (O2-) and hydroperoxyl radicals (HO2) in dimethyl sulfoxide as an aprotic solvent. It was found that the ginkgolides B, C, J, M as well as bilobalide react with superoxide and its protonated form as demonstrated by EPR and UV/VIS spectroscopy. The initial reaction rate with these oxygen-derived radicals is in the order of 100 M-1/s and below. Ginkgolide A does not react with superoxide under these conditions. From these findings it can be suggested that the superoxide scavenging effect of the ginkgolides B, C, J, M and bilobalide contributes to the antioxidant properties of G. biloba.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413545     DOI: 10.1016/s0009-2797(97)00067-7

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

Review 1.  Prevention of Alzheimer's disease: where we stand.

Authors:  Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  Ginkgo extract EGb 761(®) shields from slowly accumulating neurodegenerative-like changes in a newly developed cell culture model induced by the combined action of low doses of antimycin A1 and 2-deoxy-D-glucose.

Authors:  Konstanze Plaschke; Marion Bergmann; Jürgen Kopitz
Journal:  J Neural Transm (Vienna)       Date:  2011-04-09       Impact factor: 3.575

Review 3.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 4.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

5.  Effects of bilobalide on hypoxia/hypoglycemia-stimulated glutamate efflux from rat cortical brain slices.

Authors:  Lisa Johns; Alan J Sinclair; John A Davies
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

Review 6.  Nanotechnological approaches for the development of herbal drugs in treatment of diabetes mellitus - a critical review.

Authors:  Saritha Marella; Naga Venkata Krishna Vara Prasad Tollamadugu
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

7.  Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.

Authors:  Orest Szczurko; Neil Shear; Anna Taddio; Heather Boon
Journal:  BMC Complement Altern Med       Date:  2011-03-15       Impact factor: 3.659

Review 8.  Neuroprotection in Glaucoma: Old and New Promising Treatments.

Authors:  Dario Rusciano; Salvatore Pezzino; Maria Giulia Mutolo; Rossella Giannotti; Aloisa Librando; Nicola Pescosolido
Journal:  Adv Pharmacol Sci       Date:  2017-10-17

Review 9.  Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

10.  Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity.

Authors:  Jie Song; Dan Liu; Liang Feng; Zhenhai Zhang; Xiaobin Jia; Wei Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.